Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine

Journal of Anesthesia

Volumn 19, Issue 1, 2005, Pages 31-35

  Hayashida, Masakazu ^a   Fukuda, Ken Ichi ^b   Fukunaga, Atsuo ^c   Meno, Aki ^d   Sato, Kanako ^d   Tarui, Kaoru ^d   Arita, Hideko ^d   Kaneko, Yuzuru ^b   Hanaoka, Kazuo ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Adenosine 5 triphosphate; Ketamine; Lidocaine; Neuropathic pain; Postherpetic neuralgia

Indexed keywords

ADENOSINE TRIPHOSPHATE; KETAMINE; LIDOCAINE; PLACEBO;

ADULT; AGED; ALLODYNIA; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; NAUSEA; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; SCORING SYSTEM; TACTILE STIMULATION; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, LOCAL; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PAIN, INTRACTABLE; PHYSICAL STIMULATION;

EID: 13444292528     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-004-0273-1     Document Type: Article

References (21)

1. Bonezzi C, Demartini L (1999) Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl 173:25-35
2. Fields HL, Rowbotham M, Baron R (1998) Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 5:209-227
3. Pappagallo M, Oaklander AL, Quatrano-Piacentini AL, Clark MR, Raja SN (2000) Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology 92:691-698
4. Kvarsnstrom A, Karlsten R, Quiding H, Emanuelsson BM, Gordh T (2003) The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesth Scand 47:868-877
5. Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P (1995) Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain. Pain 61:155-158
6. Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P (1995) Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 81:713-717
7. Segerdahl M, Sollevi A (1998) Adenosine and pain relief: A clinical overview. Drug Dev Res 45:151-158
8. Sjolund KF, Belfrage M, Karlsten R, Segerdahl M, Arner S, Gordh T, Solevi A (2001) Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: A multi-centre, placebo-controlled study. Eur J Pain 5:199-207
9. Lynch ME, Clark AJ, Sawynok J (2003) Intravenous adenosine alleviates neuropathic pain: A double blind placebo controlled crossover trial using an enriched enrollment design. Pain 103:111-117
10. Agteresch HJ, Dagnelie PC, van den Berg JWO, Wilson JHP (1999) Adenosine triphosphate: Established and potential clinical applications. Drugs 58:211-232
11. Guieu R, Sampieri F, Pouget J, Guy B, Rochat H (1994) Adenosine in painful legs and moving toes syndrome. Clin Neuropharmacol 17:460-469
12. Hayashida M, Sato K, Fukunaga A, Fukuda K, Sekiyama H, Sawamura S, Arita H, Hanaoka K (2004) Intravenous infusion of adenosine 5′-triphosphate alleviated a disabling postherpetic neuralgia. J Anesth 18:36-38
13. Kato J, Ogawa S, Tamura M, Kashiwazaki M, Nakamura T, Saeki S (1999) Pharmacological tests in 100 patients with intractable pain. Pain Res 14:89-95
14. Haskell CM, Wong M, Williams A (1996) Phase I trial of extracellular lular adenosine 5′-triphosphate in patients with advanced cancer. Med Pediatr Oncol 27:165-173
15. Sollevi A (1991) Effect of adenosine infusion in the conscious man. In: Phillis JW (ed) Adenosine and adenosine nucleotides as regulators of cellular function. CRC, Boca Raton, pp 283-291
16. Segerdahl M, Sollevi A (1998) Adenosine and pain relief: A clinical overview. Drug Dev Res 45:151-158
17. Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 317:1-11
18. Fukunaga AF, Hayashida MA, Hoss S (2001) Characteristic of adenosine-induced analgesia in a rabbit model for acute pain: A comparative study with remifentanil. Anesthesiology 95:A736
19. Arita H, Suzuki M, Meno A, Sekiyama H, Hayashida M, Sumida T, Hanaoka K (2002) Clinical application of ketamine capsules and sublingual tablets to intractable pain patients. In: Varrassi G (ed) Recent views on clinical pain. Monduzzi, Bologna, Italy, pp 323-326
20. Eide K, Stubhaug A, Oye I, Breivik H (1995) Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 61:221-228
21. Karlsten R, Gordh T Jr. (1995) An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 80:844-847